In the state of hyperglycemia, abnormal expression of MIOX activates NLRP3 inflammasomes, leading to increased release of inflammatory mediators, promoting inflammatory response, leading to pancreatic cell damage, and exacerbating insulin resistance. Here, MIOX is linked to Hyperglycemia.